NCT03301350 2026-02-13
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
University of Wisconsin, Madison
Phase 2 Completed
University of Wisconsin, Madison
University of Kansas Medical Center
The Methodist Hospital Research Institute
Hoffmann-La Roche
Hoffmann-La Roche